The global Epigenome Analysis Services market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Epigenome Analysis Services Industry Forecast” looks at past sales and reviews total world Epigenome Analysis Services sales in 2023, providing a comprehensive analysis by region and market sector of projected Epigenome Analysis Services sales for 2024 through 2030. With Epigenome Analysis Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epigenome Analysis Services industry.
This Insight Report provides a comprehensive analysis of the global Epigenome Analysis Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Epigenome Analysis Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epigenome Analysis Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epigenome Analysis Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epigenome Analysis Services.
United States market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Epigenome Analysis Services players cover Cellcentric, Syndax, Illumina, Merck and QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Epigenome Analysis Services market by product type, application, key players and key regions and countries.
Segmentation by type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segmentation by application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Epigenome Analysis Services Market Size 2019-2030 2.1.2 Epigenome Analysis Services Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Epigenome Analysis Services Segment by Type 2.2.1 DNA Methylation Analysis 2.2.2 Analysis of DNA Interactions 2.2.3 Chromatin Accessibility 2.2.4 Conformation Assays 2.3 Epigenome Analysis Services Market Size by Type 2.3.1 Epigenome Analysis Services Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Epigenome Analysis Services Market Size Market Share by Type (2019-2024) 2.4 Epigenome Analysis Services Segment by Application 2.4.1 Research Institutes 2.4.2 Pharmaceutical Companies 2.4.3 Biotechnology Companies 2.4.4 Others 2.5 Epigenome Analysis Services Market Size by Application 2.5.1 Epigenome Analysis Services Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Epigenome Analysis Services Market Size Market Share by Application (2019-2024) 3 Epigenome Analysis Services Market Size by Player 3.1 Epigenome Analysis Services Market Size Market Share by Players 3.1.1 Global Epigenome Analysis Services Revenue by Players (2019-2024) 3.1.2 Global Epigenome Analysis Services Revenue Market Share by Players (2019-2024) 3.2 Global Epigenome Analysis Services Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Epigenome Analysis Services by Regions 4.1 Epigenome Analysis Services Market Size by Regions (2019-2024) 4.2 Americas Epigenome Analysis Services Market Size Growth (2019-2024) 4.3 APAC Epigenome Analysis Services Market Size Growth (2019-2024) 4.4 Europe Epigenome Analysis Services Market Size Growth (2019-2024) 4.5 Middle East & Africa Epigenome Analysis Services Market Size Growth (2019-2024) 5 Americas 5.1 Americas Epigenome Analysis Services Market Size by Country (2019-2024) 5.2 Americas Epigenome Analysis Services Market Size by Type (2019-2024) 5.3 Americas Epigenome Analysis Services Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Epigenome Analysis Services Market Size by Region (2019-2024) 6.2 APAC Epigenome Analysis Services Market Size by Type (2019-2024) 6.3 APAC Epigenome Analysis Services Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Epigenome Analysis Services by Country (2019-2024) 7.2 Europe Epigenome Analysis Services Market Size by Type (2019-2024) 7.3 Europe Epigenome Analysis Services Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Epigenome Analysis Services by Region (2019-2024) 8.2 Middle East & Africa Epigenome Analysis Services Market Size by Type (2019-2024) 8.3 Middle East & Africa Epigenome Analysis Services Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Epigenome Analysis Services Market Forecast 10.1 Global Epigenome Analysis Services Forecast by Regions (2025-2030) 10.1.1 Global Epigenome Analysis Services Forecast by Regions (2025-2030) 10.1.2 Americas Epigenome Analysis Services Forecast 10.1.3 APAC Epigenome Analysis Services Forecast 10.1.4 Europe Epigenome Analysis Services Forecast 10.1.5 Middle East & Africa Epigenome Analysis Services Forecast 10.2 Americas Epigenome Analysis Services Forecast by Country (2025-2030) 10.2.1 United States Epigenome Analysis Services Market Forecast 10.2.2 Canada Epigenome Analysis Services Market Forecast 10.2.3 Mexico Epigenome Analysis Services Market Forecast 10.2.4 Brazil Epigenome Analysis Services Market Forecast 10.3 APAC Epigenome Analysis Services Forecast by Region (2025-2030) 10.3.1 China Epigenome Analysis Services Market Forecast 10.3.2 Japan Epigenome Analysis Services Market Forecast 10.3.3 Korea Epigenome Analysis Services Market Forecast 10.3.4 Southeast Asia Epigenome Analysis Services Market Forecast 10.3.5 India Epigenome Analysis Services Market Forecast 10.3.6 Australia Epigenome Analysis Services Market Forecast 10.4 Europe Epigenome Analysis Services Forecast by Country (2025-2030) 10.4.1 Germany Epigenome Analysis Services Market Forecast 10.4.2 France Epigenome Analysis Services Market Forecast 10.4.3 UK Epigenome Analysis Services Market Forecast 10.4.4 Italy Epigenome Analysis Services Market Forecast 10.4.5 Russia Epigenome Analysis Services Market Forecast 10.5 Middle East & Africa Epigenome Analysis Services Forecast by Region (2025-2030) 10.5.1 Egypt Epigenome Analysis Services Market Forecast 10.5.2 South Africa Epigenome Analysis Services Market Forecast 10.5.3 Israel Epigenome Analysis Services Market Forecast 10.5.4 Turkey Epigenome Analysis Services Market Forecast 10.5.5 GCC Countries Epigenome Analysis Services Market Forecast 10.6 Global Epigenome Analysis Services Forecast by Type (2025-2030) 10.7 Global Epigenome Analysis Services Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Cellcentric 11.1.1 Cellcentric Company Information 11.1.2 Cellcentric Epigenome Analysis Services Product Offered 11.1.3 Cellcentric Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Cellcentric Main Business Overview 11.1.5 Cellcentric Latest Developments 11.2 Syndax 11.2.1 Syndax Company Information 11.2.2 Syndax Epigenome Analysis Services Product Offered 11.2.3 Syndax Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Syndax Main Business Overview 11.2.5 Syndax Latest Developments 11.3 Illumina 11.3.1 Illumina Company Information 11.3.2 Illumina Epigenome Analysis Services Product Offered 11.3.3 Illumina Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Illumina Main Business Overview 11.3.5 Illumina Latest Developments 11.4 Merck 11.4.1 Merck Company Information 11.4.2 Merck Epigenome Analysis Services Product Offered 11.4.3 Merck Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Merck Main Business Overview 11.4.5 Merck Latest Developments 11.5 QIAGEN 11.5.1 QIAGEN Company Information 11.5.2 QIAGEN Epigenome Analysis Services Product Offered 11.5.3 QIAGEN Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 QIAGEN Main Business Overview 11.5.5 QIAGEN Latest Developments 11.6 F. Hoffmann-La Roche 11.6.1 F. Hoffmann-La Roche Company Information 11.6.2 F. Hoffmann-La Roche Epigenome Analysis Services Product Offered 11.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 F. Hoffmann-La Roche Main Business Overview 11.6.5 F. Hoffmann-La Roche Latest Developments 11.7 Eisai 11.7.1 Eisai Company Information 11.7.2 Eisai Epigenome Analysis Services Product Offered 11.7.3 Eisai Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Eisai Main Business Overview 11.7.5 Eisai Latest Developments 11.8 Abcam 11.8.1 Abcam Company Information 11.8.2 Abcam Epigenome Analysis Services Product Offered 11.8.3 Abcam Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Abcam Main Business Overview 11.8.5 Abcam Latest Developments 11.9 Diagenode 11.9.1 Diagenode Company Information 11.9.2 Diagenode Epigenome Analysis Services Product Offered 11.9.3 Diagenode Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Diagenode Main Business Overview 11.9.5 Diagenode Latest Developments 11.10 Active Motif 11.10.1 Active Motif Company Information 11.10.2 Active Motif Epigenome Analysis Services Product Offered 11.10.3 Active Motif Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Active Motif Main Business Overview 11.10.5 Active Motif Latest Developments 11.11 Zymo Research Corporation 11.11.1 Zymo Research Corporation Company Information 11.11.2 Zymo Research Corporation Epigenome Analysis Services Product Offered 11.11.3 Zymo Research Corporation Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Zymo Research Corporation Main Business Overview 11.11.5 Zymo Research Corporation Latest Developments 11.12 Thermo Fisher Scientific 11.12.1 Thermo Fisher Scientific Company Information 11.12.2 Thermo Fisher Scientific Epigenome Analysis Services Product Offered 11.12.3 Thermo Fisher Scientific Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Thermo Fisher Scientific Main Business Overview 11.12.5 Thermo Fisher Scientific Latest Developments 11.13 Enzo Life Sciences 11.13.1 Enzo Life Sciences Company Information 11.13.2 Enzo Life Sciences Epigenome Analysis Services Product Offered 11.13.3 Enzo Life Sciences Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Enzo Life Sciences Main Business Overview 11.13.5 Enzo Life Sciences Latest Developments 11.14 EpiGentek Group 11.14.1 EpiGentek Group Company Information 11.14.2 EpiGentek Group Epigenome Analysis Services Product Offered 11.14.3 EpiGentek Group Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 EpiGentek Group Main Business Overview 11.14.5 EpiGentek Group Latest Developments 11.15 New England Biolabs 11.15.1 New England Biolabs Company Information 11.15.2 New England Biolabs Epigenome Analysis Services Product Offered 11.15.3 New England Biolabs Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 New England Biolabs Main Business Overview 11.15.5 New England Biolabs Latest Developments 11.16 Epizyme 11.16.1 Epizyme Company Information 11.16.2 Epizyme Epigenome Analysis Services Product Offered 11.16.3 Epizyme Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 Epizyme Main Business Overview 11.16.5 Epizyme Latest Developments 11.17 Domainex 11.17.1 Domainex Company Information 11.17.2 Domainex Epigenome Analysis Services Product Offered 11.17.3 Domainex Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 Domainex Main Business Overview 11.17.5 Domainex Latest Developments 11.18 Agilent Technologies 11.18.1 Agilent Technologies Company Information 11.18.2 Agilent Technologies Epigenome Analysis Services Product Offered 11.18.3 Agilent Technologies Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 Agilent Technologies Main Business Overview 11.18.5 Agilent Technologies Latest Developments 11.19 AsisChem 11.19.1 AsisChem Company Information 11.19.2 AsisChem Epigenome Analysis Services Product Offered 11.19.3 AsisChem Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024) 11.19.4 AsisChem Main Business Overview 11.19.5 AsisChem Latest Developments 12 Research Findings and Conclusion